Peptide Polyagonists for the Treatment of Nonalcoholic Fatty Liver Disease | Bentham Science Publishers

2000

Volume 29, Issue 41

ISSN: 1381-6128
E-ISSN: 1873-4286

s Peptide Polyagonists for the Treatment of Nonalcoholic Fatty Liver Disease
By Stergios A. Polyzos, Gema Frühbeck and Dimitrios N. Kiortsis
Source: Current Pharmaceutical Design, Volume 29, Issue 41, Nov 2023, p. 3263 - 3265
DOI: https://doi.org/10.2174/0113816128279822231211101522
- Available online: 01 Nov 2023

Preview this article:

There is no abstract available.

© Bentham Science Publishers

Article metrics loading...

/content/journals/cpd/10.2174/0113816128279822231211101522

2023-11-01

2025-10-30

From This Site

/content/journals/cpd/10.2174/0113816128279822231211101522

dcterms_title,dcterms_subject,pub_keyword

-contentType:Contributor -contentType:Concept -contentType:Institution

10

5

Loading full text...

Full text loading...

/content/journals/cpd/10.2174/0113816128279822231211101522

Article Type: Editorial

Keyword(s): Efinopegdutide; glucagon; glucagon-like peptide-1 receptor agonists; glucose-dependent insulinotropic polypeptide; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; retatrutide; tirzepatide

Most Cited Most Cited RSS feed

This is a required field

Please enter a valid email address

Approval was a Success

Invalid data

An Error Occurred

Approval was partially successful, following selected items could not be processed due to error

Please enter a valid_number test